FDA inspection
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site): FDA inspection ending Jan 16, 2024
FDA inspection 1229376 · Official Action Indicated (OAI) · Lianyungang
Key facts
| Inspection ID | 1229376 |
|---|---|
| Firm | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) |
| FEI number | 3007373503 |
| Address | Dev. Zone, Economic & Technological; 38 Huanghe Avenue |
| City | Lianyungang |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Jan 16, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 679790 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data